Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | -1.49% | -3.41% | -36.74% |
03-28 | Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-28 | Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.74% | 2.7M | |
+18.57% | 39.6B | |
-.--% | 11.15B | |
+2.84% | 8.09B | |
+1.03% | 6.4B | |
-1.32% | 6.22B | |
-5.22% | 5.63B | |
+35.64% | 5.37B | |
-15.75% | 5.25B | |
-18.83% | 4.3B |
- Stock Market
- Equities
- RKDA Stock
- News Arcadia Biosciences, Inc.
- Arcadia Biosciences : Lake Street Initiates Coverage on Arcadia Biosciences With Buy Rating, $4.50 Price Target